Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Heart Rhythm. 2012 Jan 28;9(6):892–898. doi: 10.1016/j.hrthm.2012.01.020

Table 1.

Characteristics of the study population

Characteristic Men (n = 450) Women (n = 601) P
ECG parameters
 Overall QTc (ms) 473 ± 55 486 ± 55 <.001
  Age ≤ 13 y 486 ± 53 485 ± 54 .21
  Age > 13 y 460 ± 53 487 ± 56 <.001
QTc > 500 ms (%) 22 27 .09
RR (ms) 842 ± 220 837 ± 199 .55
Mutation location (%)
 Cytoplasmic loop (S2–S3 or S4–S5 IDL) 19 19 .92
 MS 53 54 .67
 N/C terminus 28 26 .58
Mutation type (%)
 Missense 83 79 .13
LQTS therapies during follow-up (%)
 Beta-blockers 45 46 .74
 Pacemaker 1.6 1.5 .94
 ICD 4 9 .003
 LCSD 1.1 0.5 .30
Cardiac events during follow-up (%)
 Syncope 35 36 .84
 ACA 3 4 .22
 SCD 13 8 .007
 Appropriate ICD shocks 0.2 1.7 .03
 ACA or SCD* 15 11 .07

Values are mean ± SD unless otherwise indicated.

ACA = aborted cardiac arrest; ECG = electrocardiogram; ICD = implantable cardioverter defibrillator; LCSD = left cervical sympathetic denervation; LQTS = long QT syndrome; MS = membrane spanning; QTc = corrected QT interval; SCD = sudden cardiac death; SD = standard deviation.

*

Only the first event for each patient was considered.